Key facts
- This page summarizes Roy D. Baynes's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Jun 2022, 16:48.
Roy D. Baynes - 23 Jun 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Reporting relationship
- Director
- Issuer ticker
- ATRA
- Reported as of
- 23 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 Jun 2022, 16:48:09 UTC
- Prior SEC filing
- 01 Jun 2022
- Next SEC filing
- 02 Sep 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Tucker, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Roy D. Baynes filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 27 Jun 2022.
Change
- Previous filing in this sequence was filed on 01 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATRA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +20,500
- Change %
- +89%
- Price
- $0.000000
- Shares after
- 43,500
- Date
- 23 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATRA
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +31,500
- Change %
- Price
- $0.000000
- Shares after
- 31,500
- Date
- 23 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 31,500
- Exercise price
- $7.35
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
Footnote F2
The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.